Causal Pathways to population health impact of HIV antiretroviral treatment

$446,321R01FY2016HDNIH

Kwazulu-Natal Research Institute Tb-Hiv, Durban

Investigators

Frank Courteney Tansercontact Till Barnighausen

Linked publications, trials & patents

Paper 39259239 Paper 39066467 Paper 38889120 Paper 38726557 Paper 38695099 Paper 38562824 Paper 37068847 Paper 36962341 Paper 36261238 Paper 36219271 Paper 36201706 Paper 35961350 Paper 35929226 Paper 35679340 Paper 35672845 Paper 35617114 Paper 35429309 Paper 35081613 Paper 34789286 Paper 34582438 Paper 34510009 Paper 34309633 Paper 34244424 Paper 33883186 Paper 33789340 Paper 33587438 Paper 33586911 Paper 33526039 Paper 33427073 Paper 33387135 Paper 33138623 Paper 33027246 Paper 33024208 Paper 32967974 Paper 32949103 Paper 32873311 Paper 32827479 Paper 32633617 Paper 32501168 Paper 32458567 Paper 32324483 Paper 32231390 Paper 32202047 Paper 32172596 Paper 32142509 Paper 32072468 Paper 32044844 Paper 31930292 Paper 31916420 Paper 31792217 Paper 31764260 Paper 31633611 Paper 31368799 Paper 31341191 Paper 31287625 Paper 31166973 Paper 31079476 Paper 30916897 Paper 30898799 Paper 30876402 Paper 30801987 Paper 30782096 Paper 30764786 Paper 30702520 Paper 30652205 Paper 30618492 Paper 30587195 Paper 30566506 Paper 30555720 Paper 30523490 Paper 30498588 Paper 30475818 Paper 30413504 Paper 30400789 Paper 30294055 Paper 30286737 Paper 30272631 Paper 30231024 Paper 30142141 Paper 30089485 Paper 30087210 Paper 30073635 Paper 30067842 Paper 30059900 Paper 30049267 Paper 29996876 Paper 29912066 Paper 29894389 Paper 29863928 Paper 29847478 Paper 29794832 Paper 29793433 Paper 29767681 Paper 29584868 Paper 29547437 Paper 29334546 Paper 29300904 Paper 29237762 Paper 29186391 Paper 29175867

Abstract

? DESCRIPTION (provided by applicant): The scale-up of antiretroviral therapy has transformed the health of HIV-endemic populations in South Africa, with unprecedented gains in life expectancy (Bor et al. 2013) and significant reductions in HIV incidence (Tanser et al. 2013). To achieve the full potential benefits of ART scale-up, further evidence is needed on the pathways (behavioral vs. biological) through which ART coverage reduces incidence, and the reasons why so many people with HIV continue to die when life-saving ART is available. We will establish this evidence base through analysis of demographic and health surveillance data from rural KwaZulu-Natal. This research will inform interventions to maximize the impact of South Africa's ART program.

View original record on NIH RePORTER →